L, Z., F, C., S, G., X, W., L, G., Y, L., . . . S, Y. (2020). Methotrexate (MTX) Plus Hydroxychloroquine versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Dove Medical Press.
Style de citation Chicago (17e éd.)L, Zhang, Chen F, Geng S, Wang X, Gu L, Lang Y, Li T, et Ye S. Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)L, Zhang, et al. Methotrexate (MTX) Plus Hydroxychloroquine Versus MTX Plus Leflunomide in Patients with MTX-Resistant Active Rheumatoid Arthritis: A 2-Year Cohort Study in Real World. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.